CALM3 mutation associated with long QT syndrome
- PMID: 25460178
- PMCID: PMC4907373
- DOI: 10.1016/j.hrthm.2014.10.035
CALM3 mutation associated with long QT syndrome
Keywords: Arrhythmia; CALM3; Calcium channel inactivation; Calmodulin; Genetics; Long QT syndrome.
Conflict of interest statement
Michael J. Ackerman is a consultant for Boston Scientific, Gilead Sciences, Medtronic, and St. Jude Medical and receives sales based royalties from Transgenomic for their FAMILION-LQTS and FAMILION-CPVT genetic tests. The other authors have no conflicts of interest relevant to this article to disclose.
Figures
Comment in
-
Calmodulinopathy: a genetic trilogy.Heart Rhythm. 2015 Feb;12(2):423-4. doi: 10.1016/j.hrthm.2014.11.017. Epub 2014 Nov 18. Heart Rhythm. 2015. PMID: 25460856 No abstract available.
References
-
- Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21;129:399–410. - PubMed
-
- Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J. 2013 - PubMed
-
- Boczek NJ, Best JM, Tester DJ, Giudicessi JR, Middha S, Evans JM, Kamp TJ, Ackerman MJ. Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndrome. Circ Cardiovasc Genet. 2013;6:279–289. - PMC - PubMed
-
- Szperl AM, Ricano-Ponce I, Li JK, et al. Exome sequencing in a family segregating for celiac disease. Clin Genet. 2011;80:138–147. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
